[Effect of a spironolactone, potassium canrenoate, on arrhythmia of the isolated auricle induced by a digitalic drug].
D000818:Animals; D000889:Anti-Arrhythmia Agents; D001145:Arrhythmias, Cardiac / Q000139:chemically induced* / Q000517:prevention & control; D004077:Digoxin; D006168:Guinea Pigs; D006325:Heart Atria; D006914:Hydroxysteroids / Q000494:pharmacology; D007664:Ketosteroids / Q000494:pharmacology; D000451:Mineralocorticoid Receptor Antagonists; D011278:Pregnanes / Q000494:pharmacology*; D011422:Propionates / Q000494:pharmacology
D000889:Anti-Arrhythmia Agents; D006914:Hydroxysteroids; D007664:Ketosteroids; D000451:Mineralocorticoid Receptor Antagonists; D011278:Pregnanes; D011422:Propionates; D004077:Digoxin
Effet d'une spironolactone, le cancrénoate de potassium, sur l'arrythmie de l'oriellette isolée induite par un digitaligue.